Durongpisitkul Kritvikrom, Laohaprasitiporn Duangmanee, Chanthong Prakul, Panchavinnin Pradit
Division of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
J Med Assoc Thai. 2005 Feb;88(2):269-74.
Balloon expandable stents have been used to manage coarctation of the aorta (Co) in selected patients with very encouraging results.
The authors report here the first group of patients with Co who underwent a successful implantation of the new Palmaz Genesis stent with intermediate term follow up.
There were 5 patients with an age range from 14 to 23 years old. All of them had significant Co and were receiving multiple anti-hypertensive medications. Primary stenting was performed in all patients. All of them had an immediate relief of the gradient. All antihypertensive medications were discontinued immediately in 4 patients. All patients had one year follow up which revealed a minimum gradient. One patient continues to receive oral antihypertensive medication.
In patients with coarctation of the aorta (native or recoarctation of aorta), stent implantation may be a feasible and improved option to relieve the stenosis. Short and mid term followup of these patients have shown encouraging results.
球囊扩张式支架已被用于治疗部分特定患者的主动脉缩窄(Co),效果非常令人鼓舞。
作者在此报告首批接受新型Palmaz Genesis支架成功植入并进行中期随访的主动脉缩窄患者。
有5例患者,年龄在14至23岁之间。他们均患有严重的主动脉缩窄,且正在接受多种抗高血压药物治疗。所有患者均接受了初次支架植入。所有患者的压差均立即得到缓解。4例患者立即停用了所有抗高血压药物。所有患者均进行了一年的随访,结果显示压差最小。1例患者继续接受口服抗高血压药物治疗。
对于主动脉缩窄(原发性或主动脉再缩窄)患者,支架植入可能是缓解狭窄的一种可行且更佳的选择。对这些患者的短期和中期随访已显示出令人鼓舞的结果。